CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-31 | Ciechanover Isaac E. Chief Executive Officer | Sale | −300 | $20.01 | $6K | 378,911 |
| 2016-03-17 | DOBMEIER ERIC Director | Purchase | +3,000 | $13.86 | $42K | 5,500 |
| 2016-02-17 | Gallagher Carol Giltner Director | Sale | −1,183 | $16.30 | $19K | 94,280 |
| 2016-02-17 | Soffer Gad Chief Operating Officer | Sale | −1,928 | $16.07 | $31K | 132,293 |
| 2016-02-17 | Soffer Gad Chief Operating Officer | Sale | −3,783 | $17.13 | $65K | 128,510 |
| 2016-02-16 | Fust Matthew K Director | Exercise or conversion | +1,603 | 12,286 | ||
| 2016-02-16 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,603 | 13,354 | ||
| 2016-02-16 | Gallagher Carol Giltner Director | Exercise or conversion | +1,548 | 94,646 | ||
| 2016-02-16 | Gallagher Carol Giltner Director | Exercise or conversion | +817 | 95,463 | ||
| 2016-02-16 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −1,548 | 12,388 | ||
| 2016-02-16 | Gallagher Carol Giltner Director | Exercise or conversion · Restricted Stock Units | −817 | 7,083 | ||
| 2016-02-16 | Soffer Gad Chief Operating Officer | Exercise or conversion | +9,615 | 130,075 | ||
| 2016-02-16 | Soffer Gad Chief Operating Officer | Exercise or conversion | +4,146 | 134,221 | ||
| 2016-02-16 | Soffer Gad Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −9,615 | 44,872 | ||
| 2016-02-16 | Soffer Gad Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −4,146 | 31,784 | ||
| 2016-02-16 | Haqq Christopher Chief Medical Officer | Exercise or conversion | +829 | 298,448 | ||
| 2016-02-16 | Haqq Christopher Chief Medical Officer | Sale | −3,208 | $15.43 | $49K | 295,240 |
| 2016-02-16 | Haqq Christopher Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −829 | 6,357 | ||
| 2016-02-16 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +7,211 | 84,853 | ||
| 2016-02-16 | Clark Mitchall G. Chief R & QA Officer | Sale | −4,153 | $15.35 | $64K | 80,700 |
Page 55 of 71 · 1,403 trades